This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Healthcare Regulatory Affairs Outsourcing Market

Surge in R&D investment to Drive the Demand for Healthcare Regulatory Affairs Outsourcing: FMI Presents Detailed analysis in 30+ Countries

Healthcare Regulatory Affairs Outsourcing Market by Services, by End User & Region – Forecast 2023–2033

Healthcare Regulatory Affairs Outsourcing Market Outlook (2023-2033)

The healthcare regulatory affairs outsourcing market is expected to grow at a CAGR of 11.3% during the forecast period. The market is valued at US$ 2 Bn as of 2023, and by 2033, the market is expected to hit a valuation of US$ 5.8 Bn.

Some of the Factors Which are Expected to Surge the Medical Affairs Outsourcing Market Growth are:

  • Increasing cases of chronic ailments
  • High cost of R&D activities, which augments the volume of clinical trial applications and product registration
  • Surging focus on novel drug development

Approval time of drugs and other medical equipment is a costly, time-consuming, and documentation-centric procedure, because of which the companies have to face a lot of pressure. Such situations are leading to a surging adoption of healthcare regulatory affairs outsourcing.

The functions pertaining to regulatory affairs are challenging, and a surging demand to obtain approval for the new products and maintaining the compliance is expected to surge the market share.

With increasing focus on novel drug development in the healthcare sector, various firms are partnering with outsourcing companies for faster documentation and approvals.

Apart from that, the healthcare companies which are expanding worldwide are looking for speedy approvals in local markets. This might surge the demand for healthcare regulatory affairs outsourcing during the forecast period.

Moreover, there are increasing cases of outsourcing local regulatory support in smaller and financially attractive markets while keeping activities related to high-relevance countries for the in-house management.

On the other hand, switching to CROs costs money for the organisations. The corporation may decide to adjust its outsourcing policy such that it internally sources regulatory affairs work instead, which would result in higher operational costs.

Additionally, organisations fear that outsourcing regulatory affairs work to CROs may result in the loss of important internal capabilities. Given that when outsourced regulatory knowledge is needed, the situation in a firm may be urgent, it is crucial that CROs have enough resources to acquire flexibility. These factors might induce a decline in the growth rate for the medical device affairs outsourcing market.

The Asia Pacific region is the largest market, having a share of more than 40%. The region is also expected to witness the highest CAGR during the forecast period. This can be attributed to the increasing number of companies trying to enter developing economies, such as India and China. Furthermore, the availability of a skilled workforce in the region at lower costs is also expected to drive the market growth.

Attributes

Value

Healthcare Regulatory Affairs Outsourcing Market Value (2022)

US$ 1.8 Bn

Healthcare Regulatory Affairs Outsourcing Market Value (2023)

US$ 2 Bn

Healthcare Regulatory Affairs Outsourcing Market Forecast Value (2033)

US$ 5.8 Bn

Healthcare Regulatory Affairs Outsourcing Market Expected CAGR (2023 to 2033)

11.3%

Customize this Report

Let us know your requirement to get
100% FREE customization

Historical CAGR (2017-2022) vs Anticipated CAGR

There is hardly any difference between the historical CAGR and the anticipated CAGR. But a slight dip has been observed owing to tight regulations that were put in place during the pandemic, which presented a whole new picture of post-pandemic regulatory affairs outsourcing. While the historical CAGR was 11.8%, the anticipated CAGR is 11.3%.

Short-term growth (2023-2026): In this period, the market might witness the expansion of the healthcare sector worldwide. This would compel biotechnology and pharmaceutical companies to outsource regulatory affairs to save costs and leverage the expertise available with Contract Research Organizations (CROs). This would allow companies to save time and improve their core competencies, which is a chief driver of the market.

Medium-term growth (2026-2029): During this period, regulatory support might be available for most of the processes across clinical trials. The verticals include manufacturing and controls (CMC), medial report writing, regulatory chemistry, data management, country regulatory affairs, regulatory strategy, and labeling & liaison. This might be attributed to the fact that the market may witness growth.

Long-term growth (2029-2033): If the market continues progressing as per the analysis, the majority of the companies would outsource the non-core activities to experts. This would enable healthcare organizations to focus on their marketing and research and development activities. In the long run, companies can benefit from product approvals, optimized reimbursements, and increased productivity. Owing to these factors, the market is anticipated to witness an upward trajectory in growth over the forecast period, opines FMI.

Drivers for Healthcare Regulatory Affairs Outsourcing Market

Cost Effective Solution

The market is expected to witness an upsurge in subcontracting vital functional accomplishments, especially in field-based medical teams, medical publications and medical material. Healthcare regulatory affairs outsourcing provides an affordable and flexible solution to address challenges and demands faced by an enterprise. Moreover, the procedures associated are becoming stringent due to increased association with regulatory authorities worldwide. Apart from that, the implementation of outsourcing solutions would assist firms in reducing the number of in-house employees and prioritizing important activities. This would help the companies in optimizing the workload and centralise certain crucial functions as well, and provide efficient regulatory consulting.

Surging Investment in R&D

Increased investment in R&D has led to the development of many innovative products in the market. With stringent regulations, strategic collaborations among the clinical research firms, drug developers and CMOs might alleviate the risk. Contract Manufacturing Organisations assist the corporation to reduce risk so that companies can focus on the vital dealings. Thus, surging R&D activities coupled with patent expirations are expected to bring positiveeffects on the healthcare regulatory affairs outsourcing market key trends and opportunities.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How Will Optimization of Vendor Networks Impact Market?

In the last few years, the optimization of vendor networks in large pharmaceutical companies has gained traction at a significant pace. To speed up the regulatory process, companies are trying to reduce the number of vendors to ensure a consistent and higher quality service.

This also enabled companies to apply a centralized approach, reduce resources required for vendor oversight, and achieve higher effectiveness and efficiency. In addition to this, outsourcing via third-party vendors is gaining traction, which again, leads to a significant reduction in costs.

Outsourcing vendor management offers process standardization and consistency, transparency, and effective governance. This trend is more prevalent in clinical operations, however, within the last few years it has become highly sought-after in regulatory affairs and pharmacovigilance.

Further, companies are investing in innovative outsourcing services providers to ensure high-quality delivery. Large pharmaceutical companies are trying to achieve higher quality standards than the minimum target set by regulatory bodies.

By choosing innovative vendors over generic ones, companies are paying more attention to management and governance, quality and compliance, regulatory intelligence process, team experience and engagement, and the vendor's internal structure and procedures. Through this, they are attempting to speed up the clinical trials and product approval process, which is expected to boost the healthcare regulatory affairs outsourcing market in the forthcoming years.

Cost of Outsourcing to be a Major Restraint

The outsourcing cost of regulatory affairs is quite high, and the companies or organizations which opt to outsource regulatory affairs may not be in a state to conduct an in-house evaluation. Furthermore, during outsourcing, there must be risk management plan, which include considerations of cost if the outsourcing of regulatory affairs is discontinued. This as well is expected to present a dipping curve in the healthcare regulatory affairs outsourcing adoption trends.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Comparative View for Healthcare Regulatory Affairs Outsourcing Market

Healthcare Regulatory Affairs Outsourcing Market:

Attributes

Healthcare Regulatory Affairs Outsourcing Market

Anticipated CAGR (2023 to 2033)

11.3%

Market Value (2023)

US$ 2 Bn

Growth Factor

Cost effective method, and rising investment in R&D

Future Opportunities

Surging focus on novel drug development

Market Trends

Optimisation of vendor networks driving the market

Outsourced Testing Services Market:

Attributes

Outsourced Testing Services Market

Anticipated CAGR (2023 to 2033)

7.7%

Market Value (2023)

US$ 39.5 Bn

Growth Factor

Prevalence of pathogenic viral disease

Future Opportunities

Increased investment in R&D by key players

Market Trends

Emerging economies are investing in this market

Healthcare IT Outsourcing Market:

Attributes

Healthcare IT Outsourcing Market

Anticipated CAGR (2023 to 2033)

7.2%

Market Value (2023)

US$ 53,500 Mn

Growth Factor

Ability to monitor health of the patient digitally

Future Opportunities

Increasing demand to curb healthcare costs

Market Trends

Market is witnessing number of cyber security threats

Country-wise Insights

Regions North America
Countries United States
CAGR (2023-2033) 11.2%
Regions Europe
Countries UK
CAGR (2023-2033) 12.1%
Regions Asia Pacific
Countries China
CAGR (2023-2033) 14.1%
Regions Asia Pacific
Countries India
CAGR (2023-2033) 17.2%
Regions Asia Pacific
Countries Japan
CAGR (2023-2033) 12.9%

Why is the U.S. Healthcare Regulatory Affairs Outsourcing Market Witnessing High Demand?

The U.S. is expected to emerge as a lucrative pocket owing to the presence of a robust healthcare sector and various small and large pharmaceutical and biotechnological companies. As per FMI, sales in the North American market are projected to command 30% of the total market share in 2022.

Attributes

Details

US Market Expected Size (2033)

US$ 1.5 Bn

US Market Absolute Dollar Growth (US$ Mn/Bn)

US$ 978.1 Mn

CAGR % 2017 to 2022

10.1%

Stringent compliances issued by regulatory authorities are encouraging collaborations between drug developers and clinical research organizations (CROs) and Contract Manufacturing Organizations. (CMOs) to mitigate potential risks and speed up the approval process.

In addition to this, various generic drugs are reaching their expiration dates, which is expected to boost sales in the market. Increasing research and development for novel drugs, vaccines, and medical equipment in the U.S. will continue augmenting the growth of the market in the forthcoming years.

How will the U.K. Healthcare Regulatory Affairs Outsource Market Fare?

Demand in the Europe market is projected to account for 23% of the total market share in 2022, with the U.K. emerging as a lucrative pocket over the forecast period.

The license for marketing and authorization of new drugs in the U.K. is granted by a regulatory authority, allowing the product to be sold by a license holder in countries covered by the regulatory authority.

Attributes

Details

UK Market Expected Size (2033)

US$ 245.1 Mn

UK Market Absolute Dollar Growth (US$ Mn/Bn)

US$ 167 Mn

CAGR % 2017 to 2022

11.9%

From January 2021, the Medicines and Healthcare Products Regulatory Agency (MHRA) carried out the licensing of new medicines in England, Scotland, and Wales. In Northern Ireland, new medicines are being licensed by the European Commission, following the recommendations from the European Medicines Agency (MEA).

Further, the National Institute for Health and Care Excellence (NICE) for England and Wales and the Scottish Medicines Consortium (SMC) for Scotland appraise certain new medicines and investigate issues such as cost-effectiveness and efficacy in new treatments.

Due to the extensive approval process, demand for outsourcing services is on the rise. This trend is expected to continue over the forecast period, thereby fueling the growth of the market.

Why is the China Healthcare Regulatory Affairs Outsourcing Market Considered Attractive?

Favorable government investments and policies in the expansion of the healthcare sector in China are expected to place it as an attractive pocket in the Asia Pacific market. Demand in the Asia Pacific market is projected to hold 27.4% of the total market share in 2022.

Attributes

Details

China Market Expected Size (2033)

US$ 539 Mn

China Market Absolute Dollar Growth (US$ Mn/Bn)

US$ 394.9 Mn

CAGR % 2017 to 2022

13.3%

Various pharmaceutical companies are aiming to expand their presence in China, which will require them to invest in outsourcing services for documentation, clinical trial applications, product registrations, and legal representation. This is expected to continue boosting sales in the market.

Besides this, regional pharmaceutical companies are focusing on generic domestic drug pricing and reimbursement reforms, such as a government-backed centralized drug procurement policy. This ensures lower bid contracts and guaranteed sales volume of drugs.

Lower costs are encouraging generic drug industry consolidation. However, companies are also focusing on global expansion, which in turn is spurring demand for outsourcing services for better compliance and faster drug approvals.

India Healthcare Regulatory Affairs Outsourcing Market: Driven by favorable Government Policies

The government has been implementing certain schemes which are expected to boost market growth. For example, the Universal Health Insurance Scheme is expected to cover people from all parts of society. Talking about the Indian health tech industry, the market is expected to cross a valuation of US$ 8 Bn by 2025 and is expected to grow at a CAGR of nearly 40% during the forecast period.

Attributes

Details

India Market Expected Size (2033)

US$ 382.9 Mn

India Market Absolute Dollar Growth (US$ Mn/Bn)

US$ 304.6 Mn

CAGR % 2017 to 2022

15%

Even the overseas players have started investing in the Indian market through the FDI route. The medical and surgical appliances sector reported a growth of a massive 202% in FDI infusion during the year 2021-22. Apart from that, the surging disposable income would allow the end users to make the best use of this service. This is expected to surge the healthcare regulatory affairs outsourcing market growth.

Japan’s healthcare regulatory affairs outsourcing market is driven by massive technological innovations

Japan’s pharmaceutical market is witnessing rapid growth. To address the needs of the aging population, the government is focusing on relaxing the regulatory policies and accelerating the development of new drugs into the market. This is expected to increase the demand for various regulatory outsourcing services that are required from the Service Type development to the commercialization stage of the Service Type.

Attributes

Details

Japan Market Expected Size (2033)

US$ 399 Mn

Japan Market Absolute Dollar Growth (US$ Mn/Bn)

US$ 280.1 Mn

CAGR % 2017 to 2022

12.1%

To cut the cost, the companies are focusing on outsourcing regulatory activities to the industries. This is expected to propel the growth of the healthcare regulatory affairs outsourcing market in Japan. Advancements in personalized medicine are the major factor driving the growth of the Japanese healthcare regulatory affairs outsourcing market.

Segmentation Analysis

Segment Services
Attributes Regulatory Writing and Publishing
CAGR % 2017 to 2022 10.4%
CAGR % 2023 to End of Forecast(2033) 11%
Segment End User
Attributes Mid-size Pharmaceutical Companies
CAGR % 2017 to 2022 13.2%
CAGR % 2023 to End of Forecast(2033) 11.6%

Which is the Most Preferred Healthcare Regulatory Affairs Outsourcing Service?

Based on the services, the regulatory writing and publishing segment is expected to hold the largest market share during the forecast period. This service is offered to start from the nascent stage of product development to marketing. Moreover, the segment is expected to witness growth owing to the greater adoption of outsourcing by large biopharmaceutical and medical device companies.

Moreover, sales in the clinical trial applications segment are projected to remain high over the forecast period. Growing emphasis on improving efficiency and reducing research and development costs is boosting sales in this segment. Clinical trial outsourcing allows companies to leverage therapeutic areas and operational expertise, enabling them to expand their geographical reach and access well-established processes and tools while saving costs.

Besides this, the ongoing development of specialized therapeutic drugs in areas such as oncology is expected to fuel sales in the forthcoming years. Outsourcing allows small and medium-sized companies to conduct clinical trials in areas where the company itself may not have adequate expertise or resources to develop the product independently.

Which End User Segment has the Largest Market Share?

Mid-size pharmaceutical companies are expected to hold the largest healthcare regulatory affairs outsourcing market share during the forecast period. This can be attributed to the growth in biosimilar, personalized medicines, and orphan drugs, which are expected to create more demand for these services.

The biotechnology segment is expected to emerge as one of the most lucrative areas of application in the market, with demand expected to grow at a considerable pace over the assessment period.

The increasing number of documentation during drug and medical device manufacturing is spurring demand for regulatory affairs outsourcing services. Small and medium-sized biotechnology companies struggle with extensive documentation, which is compelling them to invest in outsourcing services.

In addition to this, due to strong regulations, demand for skilled professionals for handling registration, evaluation, and compliance of data is required. Owing to this factor, demand in the biotechnology segment is anticipated to gain momentum over the assessment period.

Start-up Ecosystem

The start-ups operating in the healthcare regulatory affairs outsourcing market are taking the best possible advantage of the lack of skilled professionals in the healthcare sector. Furthermore, the start-ups are also targeting healthcare firms that are based outside large cities.

The new players are focusing more on low-risk outsourcing and strategic outsourcing. The low-risk outsourcing is all about dealing with routine aspects of the business, which also happens to be the heart and soul of the business in a sense. Apart from that, it also allows start-ups to focus more on the regulatory part of the business, which is quite often outsourced. As far as strategic outsourcing is concerned, the companies only focus on the commercial aspects and outsource every other operation to these start-ups.

Competitive Landscape

The key players operating in the healthcare regulatory affairs outsourcing market are focusing on the right approach to improve access the Real World Data from Electronic Medical Records and medical insurance claims, and the technologies like wearables and sensors. For example, Parexel has a dedicated team to assess and understand clinical data, and digital services, that makes use of appropriate statistical methodologies. This would certainly allow the company to engage the right expertise based on the type of data.

Some of the recent developments in the healthcare regulatory affairs outsourcing market are:

  • In September 2022, Parexel opened clinical trial supplies and logistics depot in Suzhou.
  • In November 2022, IQVIA (formerly Quintiles) and Clait Health Services partnered to advance research by launching the first site in Israel.

The top companies are:

Company

Description

Parexel

Parexel is the world’s largest Clinical Research Organization (CROs), providing a full range of clinical development services to help life-saving treatments reach patients faster. Our team of more than 19,000 global professionals works with biopharmaceutical firms, upcoming innovators, and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere.

The depth of industry knowledge we have and strong track record gained over the past 4 decades are advancing clinical research in healthcare’s most complex areas.

IQVIA

IQVIA is a leading provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. The company is dedicated to creating intelligent connections that deliver unique innovations and actionable insights.

IQVIA Connected Intelligence™ connects unparalleled data, advanced analytics, and deep healthcare and scientific expertise so that you can discover previously unseen insights, driven by smarter decision-making.

Clinilabs

Clinilabs is a global CRO which is into providing a full range of CNS drug development services to pharmaceutical and biotechnology companies, from first-in-human to Phase 3 trials.

Clinilabs collaborates with investigator sites to conduct clinical trials that lead to new drug approvals.

The company is comprised of industry leaders and experts in the field of clinical research. The team brings the best combination of scientific and operational experience to every project it runs.

Key Companies Profiled

  • PAREXEL International Corporation
  • Quintiles IMS Holdings Inc.
  • Clinilabs, Inc.
  • Accell Clinical Research, LLC
  • Freyr Solutions

Healthcare Regulatory Affairs Outsourcing Market Segmentation

By Services:

  • Regulatory Writing and Publishing,
  • Regulatory Submissions,
  • Clinical Trial Applications,
  • Product Registrations,
  • Regulatory Consulting
  • Legal Representation

By End User:

  • Mid-size Pharmaceutical Companies,
  • Large Pharmaceutical Companies,
  • Biotechnology Companies,
  • Medical Devices Manufacturer,
  • Food and Beverage Companies

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

The global healthcare regulatory affairs outsourcing market holds a valuation of US$ 2 Bn as of 2023.

The healthcare regulatory affairs outsourcing market is expected to grow at 11.3% CAGR from 2023 to 2033.

The global healthcare regulatory affairs outsourcing market is forecasted to surpass US$ 5.8 Bn by 2033.

Asia Pacific is the largest healthcare regulatory affairs outsourcing market.

The main drivers are: cost effective solution, and surging investment in R&D.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017-2022 and Forecast, 2023-2033

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2022

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2023-2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Services

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Services, 2017-2022

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Services, 2023-2033

        5.3.1. Regulatory Writing and Publishing

        5.3.2. Regulatory Submissions

        5.3.3. Clinical Trial Applications

        5.3.4. Product Registrations

        5.3.5. Regulatory Consulting and Legal Representation

    5.4. Y-o-Y Growth Trend Analysis By Services, 2017-2022

    5.5. Absolute $ Opportunity Analysis By Services, 2023-2033

6. Global Market Analysis 2017-2022 and Forecast 2023-2033, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2022

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2023-2033

        6.3.1. Mid-Size Pharmaceutical Companies

        6.3.2. Large Pharmaceutical Companies

        6.3.3. Biotechnology Companies

        6.3.4. Medical Devices Manufacturer

        6.3.5. Food & Beverage Companies

    6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2022

    6.5. Absolute $ Opportunity Analysis By End User, 2023-2033

7. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2022

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2017-2022 and Forecast 2023-2033, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Services

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Services

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Market Analysis 2017-2022 and Forecast 2023-2033, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Services

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Services

        9.3.3. By End User

    9.4. Key Takeaways

10. Europe Market Analysis 2017-2022 and Forecast 2023-2033, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        10.2.1. By Country

            10.2.1.1. U.K.

            10.2.1.2. France

            10.2.1.3. Germany

            10.2.1.4. Italy

            10.2.1.5. Spain

            10.2.1.6. Rest of Europe

        10.2.2. By Services

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Services

        10.3.3. By End User

    10.4. Key Takeaways

11. Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2033, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. India

            11.2.1.3. Japan

            11.2.1.4. ASEAN

            11.2.1.5. Australia & New Zealand

            11.2.1.6. Rest of APAC

        11.2.2. By Services

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Services

        11.3.3. By End User

    11.4. Key Takeaways

12. MEA Market Analysis 2017-2022 and Forecast 2023-2033, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Rest of MEA

        12.2.2. By Services

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Services

        12.3.3. By End User

    12.4. Key Takeaways

13. Key Countries Market Analysis

    13.1. U.S.

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2022

            13.1.2.1. By Services

            13.1.2.2. By End User

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2022

            13.2.2.1. By Services

            13.2.2.2. By End User

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2022

            13.3.2.1. By Services

            13.3.2.2. By End User

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2022

            13.4.2.1. By Services

            13.4.2.2. By End User

    13.5. U.K.

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2022

            13.5.2.1. By Services

            13.5.2.2. By End User

    13.6. France

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2022

            13.6.2.1. By Services

            13.6.2.2. By End User

    13.7. Germany

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2022

            13.7.2.1. By Services

            13.7.2.2. By End User

    13.8. Italy

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2022

            13.8.2.1. By Services

            13.8.2.2. By End User

    13.9. Spain

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2022

            13.9.2.1. By Services

            13.9.2.2. By End User

    13.10. China

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2022

            13.10.2.1. By Services

            13.10.2.2. By End User

    13.11. India

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2022

            13.11.2.1. By Services

            13.11.2.2. By End User

    13.12. Japan

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2022

            13.12.2.1. By Services

            13.12.2.2. By End User

    13.13. ASEAN

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2022

            13.13.2.1. By Services

            13.13.2.2. By End User

    13.14. Australia & New Zealand

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2022

            13.14.2.1. By Services

            13.14.2.2. By End User

    13.15. GCC Countries

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2022

            13.15.2.1. By Services

            13.15.2.2. By End User

    13.16. South Africa

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2022

            13.16.2.1. By Services

            13.16.2.2. By End User

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Services

        14.3.3. By End User

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. PAREXEL International Corporation

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. Quintiles IMS Holdings Inc.

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. Clinilabs, Inc.

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. Accell Clinical Research, LLC

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

        15.1.5. Freyr Solutions

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

        15.1.6. The Weinberg Group Inc.

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

        15.1.7. Covance, Inc., (LabCorp)

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

        15.1.8. Pharmaceutical Product Development LLC

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segments

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

        15.1.9. ICON plc

            15.1.9.1. Overview

            15.1.9.2. Product Portfolio

            15.1.9.3. Profitability by Market Segments

            15.1.9.4. Sales Footprint

            15.1.9.5. Strategy Overview

                15.1.9.5.1. Marketing Strategy

        15.1.10. Sciformix Corporation

            15.1.10.1. Overview

            15.1.10.2. Product Portfolio

            15.1.10.3. Profitability by Market Segments

            15.1.10.4. Sales Footprint

            15.1.10.5. Strategy Overview

                15.1.10.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2033

Table 2: Global Market Value (US$ Mn) Forecast by Services, 2017-2033

Table 3: Global Market Value (US$ Mn) Forecast by End User, 2017-2033

Table 4: North America Market Value (US$ Mn) Forecast by Country, 2017-2033

Table 5: North America Market Value (US$ Mn) Forecast by Services, 2017-2033

Table 6: North America Market Value (US$ Mn) Forecast by End User, 2017-2033

Table 7: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2033

Table 8: Latin America Market Value (US$ Mn) Forecast by Services, 2017-2033

Table 9: Latin America Market Value (US$ Mn) Forecast by End User, 2017-2033

Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2017-2033

Table 11: Europe Market Value (US$ Mn) Forecast by Services, 2017-2033

Table 12: Europe Market Value (US$ Mn) Forecast by End User, 2017-2033

Table 13: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2033

Table 14: Asia Pacific Market Value (US$ Mn) Forecast by Services, 2017-2033

Table 15: Asia Pacific Market Value (US$ Mn) Forecast by End User, 2017-2033

Table 16: MEA Market Value (US$ Mn) Forecast by Country, 2017-2033

Table 17: MEA Market Value (US$ Mn) Forecast by Services, 2017-2033

Table 18: MEA Market Value (US$ Mn) Forecast by End User, 2017-2033

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) by Services, 2023-2033

Figure 2: Global Market Value (US$ Mn) by End User, 2023-2033

Figure 3: Global Market Value (US$ Mn) by Region, 2023-2033

Figure 4: Global Market Value (US$ Mn) Analysis by Region, 2017-2033

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023-2033

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023-2033

Figure 7: Global Market Value (US$ Mn) Analysis by Services, 2017-2033

Figure 8: Global Market Value Share (%) and BPS Analysis by Services, 2023-2033

Figure 9: Global Market Y-o-Y Growth (%) Projections by Services, 2023-2033

Figure 10: Global Market Value (US$ Mn) Analysis by End User, 2017-2033

Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2023-2033

Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2023-2033

Figure 13: Global Market Attractiveness by Services, 2023-2033

Figure 14: Global Market Attractiveness by End User, 2023-2033

Figure 15: Global Market Attractiveness by Region, 2023-2033

Figure 16: North America Market Value (US$ Mn) by Services, 2023-2033

Figure 17: North America Market Value (US$ Mn) by End User, 2023-2033

Figure 18: North America Market Value (US$ Mn) by Country, 2023-2033

Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2017-2033

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 22: North America Market Value (US$ Mn) Analysis by Services, 2017-2033

Figure 23: North America Market Value Share (%) and BPS Analysis by Services, 2023-2033

Figure 24: North America Market Y-o-Y Growth (%) Projections by Services, 2023-2033

Figure 25: North America Market Value (US$ Mn) Analysis by End User, 2017-2033

Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2023-2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2023-2033

Figure 28: North America Market Attractiveness by Services, 2023-2033

Figure 29: North America Market Attractiveness by End User, 2023-2033

Figure 30: North America Market Attractiveness by Country, 2023-2033

Figure 31: Latin America Market Value (US$ Mn) by Services, 2023-2033

Figure 32: Latin America Market Value (US$ Mn) by End User, 2023-2033

Figure 33: Latin America Market Value (US$ Mn) by Country, 2023-2033

Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2033

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 37: Latin America Market Value (US$ Mn) Analysis by Services, 2017-2033

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Services, 2023-2033

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Services, 2023-2033

Figure 40: Latin America Market Value (US$ Mn) Analysis by End User, 2017-2033

Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2023-2033

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023-2033

Figure 43: Latin America Market Attractiveness by Services, 2023-2033

Figure 44: Latin America Market Attractiveness by End User, 2023-2033

Figure 45: Latin America Market Attractiveness by Country, 2023-2033

Figure 46: Europe Market Value (US$ Mn) by Services, 2023-2033

Figure 47: Europe Market Value (US$ Mn) by End User, 2023-2033

Figure 48: Europe Market Value (US$ Mn) by Country, 2023-2033

Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2017-2033

Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 52: Europe Market Value (US$ Mn) Analysis by Services, 2017-2033

Figure 53: Europe Market Value Share (%) and BPS Analysis by Services, 2023-2033

Figure 54: Europe Market Y-o-Y Growth (%) Projections by Services, 2023-2033

Figure 55: Europe Market Value (US$ Mn) Analysis by End User, 2017-2033

Figure 56: Europe Market Value Share (%) and BPS Analysis by End User, 2023-2033

Figure 57: Europe Market Y-o-Y Growth (%) Projections by End User, 2023-2033

Figure 58: Europe Market Attractiveness by Services, 2023-2033

Figure 59: Europe Market Attractiveness by End User, 2023-2033

Figure 60: Europe Market Attractiveness by Country, 2023-2033

Figure 61: Asia Pacific Market Value (US$ Mn) by Services, 2023-2033

Figure 62: Asia Pacific Market Value (US$ Mn) by End User, 2023-2033

Figure 63: Asia Pacific Market Value (US$ Mn) by Country, 2023-2033

Figure 64: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2033

Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 67: Asia Pacific Market Value (US$ Mn) Analysis by Services, 2017-2033

Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Services, 2023-2033

Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Services, 2023-2033

Figure 70: Asia Pacific Market Value (US$ Mn) Analysis by End User, 2017-2033

Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2023-2033

Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2023-2033

Figure 73: Asia Pacific Market Attractiveness by Services, 2023-2033

Figure 74: Asia Pacific Market Attractiveness by End User, 2023-2033

Figure 75: Asia Pacific Market Attractiveness by Country, 2023-2033

Figure 76: MEA Market Value (US$ Mn) by Services, 2023-2033

Figure 77: MEA Market Value (US$ Mn) by End User, 2023-2033

Figure 78: MEA Market Value (US$ Mn) by Country, 2023-2033

Figure 79: MEA Market Value (US$ Mn) Analysis by Country, 2017-2033

Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 82: MEA Market Value (US$ Mn) Analysis by Services, 2017-2033

Figure 83: MEA Market Value Share (%) and BPS Analysis by Services, 2023-2033

Figure 84: MEA Market Y-o-Y Growth (%) Projections by Services, 2023-2033

Figure 85: MEA Market Value (US$ Mn) Analysis by End User, 2017-2033

Figure 86: MEA Market Value Share (%) and BPS Analysis by End User, 2023-2033

Figure 87: MEA Market Y-o-Y Growth (%) Projections by End User, 2023-2033

Figure 88: MEA Market Attractiveness by Services, 2023-2033

Figure 89: MEA Market Attractiveness by End User, 2023-2033

Figure 90: MEA Market Attractiveness by Country, 2023-2033

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Healthcare Interoperability Solutions Market

Published : February 2022

Healthcare

Healthcare IT Outsourcing Market

Published : July 2020

Google translate

Healthcare Regulatory Affairs Outsourcing Market